EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade



Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade



American Heart Journal 130(2): 281-286



To study prognostic factors in patients with sustained ventricular tachycardias (VT) or ventricular fibrillation (VF) complicated by left ventricular dysfunction, we evaluated the predictive value of demographic, clinical, and hemodynamic parameters for cardiac mortality and sudden cardiac death in 85 patients with VT or VF and left ventricular ejection fraction < 0.45 (mean 0.27 +/- 0.10). Patients underwent serial drug testing and received appropriate antiarrhythmic treatment, with amiodarone given as last-resort therapy. During a follow-up of 24 +/- 13 months, 23 patients died of cardiac causes, and 18 of them died suddenly. Left ventricular ejection fraction < or = 0.27 and amiodarone treatment were related to greater cardiac mortality and increased risk of sudden cardiac death, whereas beta-blockade was associated with improved survival. In the multivariate model cardiac mortality was best predicted by a left ventricular ejection fraction < or = 0.27, and absence of beta-blockade and severe left ventricular dysfunction were the strongest predictors of sudden cardiac death. We conclude that severe left ventricular dysfunction predicts increased cardiac mortality and high risk of sudden cardiac death. Moreover, beta-blocking treatment is associated with lower cardiac mortality and a reduced risk of sudden cardiac death in patients with sustained VT or VF and depressed left ventricular function. beta-Blocking agents may therefore be an important addition to conventional antiarrhythmic treatment in patients with VT or VF and left ventricular dysfunction.

(PDF emailed within 1 workday: $29.90)

Accession: 009229408

Download citation: RISBibTeXText

PMID: 7631608



Related references

Beta-Blocking therapy is a main prognostic factor of survival in patients with sustained monomorphic ventricular tachycardias due to left ventricular disease. European Heart Journal 15(ABSTR SUPPL ): 540, 1994

Reduction of left ventricular dyssynchrony after catheter ablation for isolated permanent atrial fibrillation in patients with depressed left ventricular function. 2007

Is interval-dependent potentiation of left ventricular contractile function preserved in patients with atrial fibrillation and depressed left ventricular ejection fraction?. Circulation 100(18 SUPPL ): I 576, Nov 2, 1999

Valve replacement in patients with critical aortic stenosis and depressed left ventricular function: predictors of operative risk, left ventricular function recovery, and long term outcome. Heart 91(10): 1324-1329, 2005

Right ventricular function in an operating room model of mechanical left ventricular assistance and its effects in patients with depressed left ventricular function. Circulation 72(6): 1279-1285, 1985

Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. Pacing and Clinical Electrophysiology 19(7): 1026-1035, 1996

Acute effects of intraoperative multisite ventricular pacing on left ventricular function and activation/contraction sequence in patients with depressed ventricular function. Journal Of Cardiovascular Electrophysiology. 9(1): 13-21,., 1998

Comparative follow up of patients with implanted cardioverter-defibrillators after induction of sustained monomorphic ventricular tachycardias or ventricular fibrillation by programmed stimulation. Heart 89(6): 629-632, 2003

Usefulness of rate regulation through continuous ventricular pacing in patients with drug-controlled slower atrial fibrillation and normal or depressed left ventricular systolic function. Heart and Vessels 23(6): 403-408, 2008

What is about patients with impaired left-ventricular function and non-sustained ventricular tachycardia being treated with beta-blockers?. European Heart Journal 24(Abstract Supplement): 719, August-September, 2003

A new magnetocardiographic algorithm for the evaluation of abnormal ventricular activation in patients with coronary heart disease and ventricular tachycardias or ventricular fibrillation. Journal of Electrocardiology 30(SUPPL ): 54, 1998

Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation. Europace 2(Supplement 1): A10-A10, 2010

Deterioration of left ventricular function following atrio-ventricular node ablation and right ventricular apical pacing in patients with permanent atrial fibrillation. Europace 4(1): 61-65, 2002

P-195 Linear and non-linear indices of heart rate variability preceding non sustained ventricular tachycardia in patients with coronary artery disease and depressed left ventricular function. Europace 4(Supplement 2): B112-B112, 2010

Association between hemodynamic parameters and the degeneration of sustained ventricular tachycardias into ventricular fibrillation in rats. Journal of Molecular and Cellular Cardiology 29(11): 3091-3103, 1998